Related content

Lipid‐specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 3, 2015-03 ,pp. : 447-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of progressive multifocal leukoencephalopathy

By O'Brien M.  

QJM: An International Journal of Medicine, Vol. 106, Iss. 3, 2013-03 ,pp. : 295-295

Oxford University Press

Access to resources Recommend Favorite

Integration of PKPD relationships into benefit–risk analysis

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 979-991

John Wiley & Sons Inc

Access to resources Recommend Favorite

Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis

By Goodin Douglas S.   Biermann Louis D.   Bohlega Saeed   Boiko Alexey   Chofflon Michel   Gebeily Souheil   Gouider Riadh   Havrdova Eva   Jakab Gabor   Karabudak Rana   Karussis Dimitrios   Miller Ariel   Pakdaman Hossein   Selmaj Krzysztof   Sharief Mohammad    

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2823-2832

Informa Healthcare

Access to resources Recommend Favorite

Chlorpromazine Combined with Cidofovir for Treatment of a Patient Suffering from Progressive Multifocal Leukoencephalopathy

By  

Intervirology, Vol. 50, Iss. 6, 2008-01 ,pp. : 412-417

Karger

Access to resources Recommend Favorite